Phenotypic and genotypic heterogeneity of glycopeptide resistance determinants in gram-positive bacteria.
about
Structure of the complex between teicoplanin and a bacterial cell-wall peptide: use of a carrier-protein approachGenetic diversity among Enterococcus faecalisMolecular analysis of Tn1546 in Enterococcus faecium isolated from animals and humansAnalysis of genes encoding D-alanine-D-alanine ligase-related enzymes in Enterococcus casseliflavus and Enterococcus flavescensVanE, a new type of acquired glycopeptide resistance in Enterococcus faecalis BM4405vanA and vanB incorporate into an endemic ampicillin-resistant vancomycin-sensitive Enterococcus faecium strain: effect on interpretation of clonalityTransfer of erythromycin resistance from poultry to human clinical strains of Staphylococcus aureus.Intraspecies genomic groups in Enterococcus faecium and their correlation with origin and pathogenicityAnalysis of peptidoglycan precursors in vancomycin-resistant Enterococcus gallinarum BM4174Possible connection between a widely disseminated conjugative gentamicin resistance (pMG1-like) plasmid and the emergence of vancomycin resistance in Enterococcus faeciumVancomycin-resistant enterococci in humans and imported chickens in Japan.VanD-type glycopeptide-resistant Enterococcus faecium BM4339.Use of primers selective for vancomycin resistance genes to determine van genotype in enterococci and to study gene organization in VanA isolates.Efficacy of vancomycin and teicoplanin alone and in combination with streptomycin in experimental, low-level vancomycin-resistant, VanB-type Enterococcus faecalis endocarditisOverproduction of a 37-kilodalton cytoplasmic protein homologous to NAD+-linked D-lactate dehydrogenase associated with vancomycin resistance in Staphylococcus aureus.Emergence of vancomycin resistance in the genus Streptococcus: characterization of a vanB transferable determinant in Streptococcus bovis.Resistance of enterococci to glycopeptides.Current perspectives on glycopeptide resistance.Toxin-antitoxin systems are ubiquitous and plasmid-encoded in vancomycin-resistant enterococci.In vitro activities of three semisynthetic amide derivatives of teicoplanin, MDL 62208, MDL 62211, and MDL 62873Characterization of glycopeptide-resistant enterococci from U.S. hospitals.Vancomycin resistance gene vanC is specific to Enterococcus gallinarumCharacterization of Tn1546, a Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147.Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR.Effects of combinations of beta-lactams, daptomycin, gentamicin, and glycopeptides against glycopeptide-resistant enterococciIn vitro activity of RP 59500, a semisynthetic injectable pristinamycin, against staphylococci, streptococci, and enterococciPharmacodynamic interaction between RP 59500 and gram-positive bacteria infecting fibrin clots.Highly conjugative pMG1-like plasmids carrying Tn1546-like transposons that encode vancomycin resistance in Enterococcus faecium.Application of DNA probes for rRNA and vanA genes to investigation of a nosocomial cluster of vancomycin-resistant enterococci.Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistanceEvidence for the genetic unrelatedness of nosocomial vancomycin-resistant Enterococcus faecium strains in a pediatric hospital.Synergism between beta-lactams and glycopeptides against VanA-type methicillin-resistant Staphylococcus aureus and heterologous expression of the vanA operonIdentification of chromosomal mobile element conferring high-level vancomycin resistance in Enterococcus faecium.Genetics and mechanisms of glycopeptide resistance in enterococci.A gene conferring resistance to vancomycin but not teicoplanin in isolates of Enterococcus faecalis and Enterococcus faecium demonstrates homology with vanB, vanA, and vanC genes of enterococci.Vancomycin-resistant Leuconostoc mesenteroides and Lactobacillus casei synthesize cytoplasmic peptidoglycan precursors that terminate in lactateVancomycin-Dependent Response in Live Drug-Resistant Bacteria by Metabolic Labeling.Teicoplanin or vancomycin in the treatment of gram-positive infections?Enterococcus, an emerging pathogen.Gene vanXYC encodes D,D -dipeptidase (VanX) and D,D-carboxypeptidase (VanY) activities in vancomycin-resistant Enterococcus gallinarum BM4174.
P2860
Q27676948-4BF0B679-70E8-4222-B031-6D87F9DF1C88Q33289954-D150DBB7-3EE4-4456-88A5-F8F3DEBA4696Q33656106-B9D278D9-C7B0-465F-B0D3-0C510587FB69Q33756700-CC8E4026-3031-44D5-BD07-005F69667B25Q33872930-D7C1180A-F7BA-4837-A0EA-E53324DB092AQ33964155-10016780-EA6C-4EFD-8387-2F18A8B84840Q33966901-F3E38371-E67E-4E63-BDAB-3DB4E9010439Q34050420-874AB1B0-C467-41B2-B887-1314CEDAD008Q34060112-C38350BA-CD54-4191-BDF5-DECE9F0FB417Q34194759-193B9D3B-BB84-413A-B23D-9311FE6742C8Q34294549-1CFF7AD6-BD08-419C-90F4-64E50BB0E66BQ34439834-9273A04E-0924-4E86-9ACE-87891251AA61Q35117264-F2A193D2-B0B3-4009-BDD1-F78B7795A668Q35121434-56EAB861-5823-4948-8E7C-595BF83D50F0Q35121917-0B3BF5C7-F35A-430A-9CA6-B3689BB32CA8Q35130751-CAA1C191-7E0E-47EE-921F-4FF356094244Q35284014-FD0A0127-9DF3-42A1-B835-A6016D724EFFQ35368590-88117A56-4606-4F29-B63E-6A49F7A35DC2Q35576011-52D83550-7385-4B88-8A0F-280E6E54A3A6Q35825738-0218E1B6-21C7-4CC0-A5C7-9C64E0531B37Q35899762-474D1539-4CA4-4ABF-9FB0-6DC6629A924CQ35900506-4055AE57-9E27-4350-96AF-569A048301DDQ35965824-7B520600-65C6-4711-9D90-5958DBDC8031Q36516947-AE6B1419-7D2F-4169-BD4C-AFD86977862FQ36752594-E73A8D51-0266-4A2C-A431-F8411A60729EQ36753160-724D91C3-E175-4134-9999-8A8475D38E4FQ36757814-64109F29-427C-4B21-8120-488DBDC0BC42Q37062645-835C1CFA-8BC0-42CA-A59C-A9A7BDD7405DQ37066214-B8656394-C358-4478-A95F-FF41931567A7Q37084637-5071F346-7FFE-4F33-877B-B76F35CF9663Q37242426-265EFEF0-47EE-4FF5-B062-AE8E69F09188Q39077455-DC4224A0-3BF8-4EDF-896C-535F9E30AF1FQ39780748-50C4C08F-758A-4970-BE9C-5638C2D671CFQ39866365-749ECE94-9108-4C05-B5A4-1C03C895F816Q39866392-78BC8942-1018-4578-AC3E-1725F60A8137Q39930098-7E280E8C-7740-40C2-854B-A5209641E3B4Q40189476-D5677A8C-DE53-4FEC-86C2-AFDD34BBDFAFQ40541603-09B6665A-58F8-4C6F-9939-03BD8A47BF03Q40785841-B7E13D40-C398-4207-9C33-302CA58D00B7Q42613869-6DB8521D-473C-400C-97F0-B7D5D1CB5367
P2860
Phenotypic and genotypic heterogeneity of glycopeptide resistance determinants in gram-positive bacteria.
description
1990 nî lūn-bûn
@nan
1990 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Phenotypic and genotypic heter ...... nts in gram-positive bacteria.
@ast
Phenotypic and genotypic heter ...... nts in gram-positive bacteria.
@en
type
label
Phenotypic and genotypic heter ...... nts in gram-positive bacteria.
@ast
Phenotypic and genotypic heter ...... nts in gram-positive bacteria.
@en
prefLabel
Phenotypic and genotypic heter ...... nts in gram-positive bacteria.
@ast
Phenotypic and genotypic heter ...... nts in gram-positive bacteria.
@en
P2093
P2860
P356
P1476
Phenotypic and genotypic heter ...... nts in gram-positive bacteria.
@en
P2093
Courvalin P
Dutka-Malen S
Leclercq R
P2860
P304
P356
10.1128/AAC.34.10.1875
P407
P577
1990-10-01T00:00:00Z